Troutman Pepper Locke Advises Luna Health in $23.6 Million Series A Financing

BERWYN – Troutman Pepper Locke advised Luna Health Inc., a medical device company pioneering a first-of-its-kind method of insulin delivery for insulin pen users, in securing its $23.6 million Series A financing. For more information, see the press release.

Luna Health will use the Series A funding to advance regulatory submissions, conduct clinical studies, build manufacturing capacity, and expand clinical and market access programs, all to make automated insulin delivery much more accessible to people with diabetes.

The Troutman Pepper Locke team that advised Luna Health was led by Jay Jumper and Matt Greenberg, with assistance from Stephen Fox, Timothy Shyu, and Jack Taylor.

Troutman Pepper Locke is very active in the emerging company and venture capital communities, advising clients through every stage of their life cycle, from formation through financing and growth, and their eventual merger, acquisition, or IPO exit. For select companies, the firm also offers the unique Troutman SEED™ program. This development program combines the resources of an experienced, multidisciplinary team into an affordable package for startups, early-stage, and fast-growing companies, providing them with comprehensive legal counsel, mentoring, relationship-building opportunities, and more.

Troutman Pepper Locke

Troutman Pepper Locke helps clients solve complex legal challenges and achieve their business goals in an ever-changing global economy. With more than 1,600 attorneys in 30+ offices, the firm serves clients in all major industry sectors, with particular depth in energy, financial services, health care and life sciences, insurance and reinsurance, private equity, and real estate. Learn more at troutman.com.